These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1452957)

  • 1. Safeguarding supplements. US Pharmacopeia sets quality standards for FDA and the supplement industry.
    Corken A
    J Am Diet Assoc; 1992 Dec; 92(12):1461. PubMed ID: 1452957
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulating vitamins and minerals.
    Hopkins H
    FDA Consum; 1976; 10(6):10-1. PubMed ID: 829226
    [No Abstract]   [Full Text] [Related]  

  • 3. [Herbal food supplements].
    Di Giorgi Gerevini V; Copparoni R; Dalfrà S; Leonardi M; Guidarelli L
    Ann Ist Super Sanita; 2005; 41(1):55-9. PubMed ID: 16037651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labeling and manufacturing standards proposed for all dietary supplements.
    Horrigan B; Block B
    Altern Ther Health Med; 2003; 9(3):22. PubMed ID: 12776471
    [No Abstract]   [Full Text] [Related]  

  • 5. Nutritional regulations and legislation--past developments, future implications.
    Harper AE
    J Am Diet Assoc; 1977 Dec; 71(6):601-9. PubMed ID: 336669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed changes in Food and Drug Administration regulations concerning formula products and vitamin-mineral dietary supplements for infants.
    Pediatrics; 1967 Nov; 40(5):916-22. PubMed ID: 6075669
    [No Abstract]   [Full Text] [Related]  

  • 7. Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.
    Melethil S
    Life Sci; 2006 Mar; 78(18):2049-53. PubMed ID: 16516243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA hearing highlights opposition to dietary supplement practices; written comments due August 20. Food and Drug Administration.
    James JS
    AIDS Treat News; 1999 Aug; (No 324):3-4. PubMed ID: 11366575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplements and other changes to an approved application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Apr; 69(68):18727-67. PubMed ID: 15072041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical decision support tools: focus on dietary supplement databases.
    Clauson KA; Peak AS; Marsh WA; DiScala S; Bellinger RR
    Altern Ther Health Med; 2008; 14(3):36-40. PubMed ID: 18517104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: FDA drug bulletin.
    Schmidt AM
    Clin Toxicol; 1974; 7(5):551-7. PubMed ID: 4442251
    [No Abstract]   [Full Text] [Related]  

  • 12. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ; Clauson KA
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 14. Federally-funded analysis attempts to undermine vitamin and mineral supplements.
    Gossard B; Schmid K; Huber L; Joyal SV
    Altern Ther Health Med; 2014; 20 Suppl 1():16-7. PubMed ID: 24473981
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ
    Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract]   [Full Text] [Related]  

  • 16. Current regulatory status of foods for special dietary uses.
    Chopra JG
    Am J Public Health; 1976 Apr; 66(4):351-3. PubMed ID: 1267078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementary evidence.
    Nurs Stand; 2005 Aug 24-30; 19(50):28-9. PubMed ID: 16138613
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA perspectives on supplement use by patients on antithrombotic therapy.
    Kim MJ
    Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the Food and Drug Administration in the regulation of the products of recombinant DNA technology.
    Goldberg M; Miller HI
    Recomb DNA Tech Bull; 1981 Apr; 4(1):15-8. PubMed ID: 7255754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.